Sumitomo Pharma America Inc - Company Profile
Powered by 
All the sales intelligence you need on Sumitomo Pharma America Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Sumitomo Pharma America Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Sumitomo Pharma America Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Business Description
Sumitomo Pharma America Inc (SMPA), formerly Sunovion Pharmaceuticals Inc, is a research-based pharmaceutical company that focuses on treatment of central nervous system disorders and respiratory disorders. The company’s drugs are used in various conditions such as anxiety disorders, depression, and pain management. It provides treatment for insomnia, epilepsy and schizophrenia.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
SMPA’s R&D activities focuses on addressing critical patient needs across multiple therapeutic areas, including oncology, urology, women's health, rare diseases, neurology & psychiatry, and cell and gene therapies. The company's pipeline includes several Phase 1 clinical trials for conditions such as myelofibrosis, acute leukemia, Parkinson’s disease, solid tumors, Alzheimer’s disease psychosis, treatment-resistant depression, glioblastoma, and a preclinical program for retinitis pigmentosa.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer